Amanote Research
Register
Sign In
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma With a GQuadruplex-Binding Small Molecule
doi 10.1021/acs.jmedchem.7b01781.s008
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma With a GQuadruplex-Binding Small Molecule
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma With a GQuadruplex-Binding Small Molecule
A Small Molecule FAK Kinase Inhibitor, GSK2256098, Inhibits Growth and Survival of Pancreatic Ductal Adenocarcinoma Cells
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Pancreatic Ductal Adenocarcinoma With Cystic Features
HPB
Hepatology
Gastroenterology
Two Birds With One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts
Cancer Discovery
Oncology
A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
Nucleic Acid Therapeutics
Biochemistry
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
A Case of Invasive Pancreatic Ductal Adenocarcinoma With Multiple Cystic Lesion and Heterotopic Bone
Suizo
Molecular Targeting of Cell-Permeable Peptide Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation
Oncotarget
Oncology
Targeting the Prohibitin Scaffold-Craf Kinase Interaction in RAS-ERK-driven Pancreatic Ductal Adenocarcinoma
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
